AMAG Pharmaceuticals AMAG
-
AMAG Pharmaceuticals ([[ AMAG ]] -12.9%) says it's hired William K. Heiden as its new president and CEO, and plays down talk of a sale of the company. Baird cuts the shares to neutral on the news, ...
AMAG Pharmaceuticals ( AMAG -12.9% ) says it's hired William K. Heiden as its new president ..... that while a take-out was by no means its sole investment thesis, AMAG 's new direction - switching roles from seller to buyer - introduces …
-
Amag names new CEO, allows shareholder to raise stake
(Reuters) - Biopharmaceutical company Amag Pharmaceuticals Inc named William Heiden as its CEO, and allowed largest shareholder Adage Capital to raise its stake in the company up to 25 percent.
-
AMAG Pharmaceuticals , Inc. AMAG Q1 2012 Earnings Call Transcript
… time, I would like to welcome everyone to the AMAG Pharmaceuticals Incorporated First 2012 Financial Results Conference ..... Good afternoon. I'd like to welcome you to the AMAG Pharmaceuticals ' first quarter 2012 financial results conference …
-
UPDATE 2- Amag's anemia drug meets late-stage goals
March 7 (Reuters) - Amag Pharmaceuticals said its anemia drug met the main goals of a late-stage trial, bringing it a step closer to broadening the patient population.
-
AMAG Pharmaceuticals ( AMAG ) +6.8% AH after announcing positive preliminary results for the first of 2 Phase III studies for its Feraheme drug. The results suggests Feraheme could be effective in ...
AMAG Pharmaceuticals ( AMAG ) +6.8% AH after announcing positive preliminary results for the ..... deficiency regardless of its cause, rather than simply for kidney disease. AMAG plans to submit a supplemental NDA to the FDA that would allow it to …
-
AMAG Pharmaceuticals , Inc. AMAG Q4 2011 Earnings Call Transcript
… time, I would like to welcome everyone to the AMAG Pharmaceuticals Financial Results Fourth Quarter and Year End 2011 ..... afternoon. I would like to welcome you to the AMAG Pharmaceuticals ' fourth quarter 2011 financial results conference …
-
AMAG Pharmaceuticals ([[ AMAG ]] -5.8%) trades lower after the company says it expects Q4 sales to come in below consensus. It now expects revenue in the range of $14.3M - $15M, below analysts' ...
AMAG Pharmaceuticals ( AMAG -5.8% ) trades lower after the company says it expects Q4 sales to come in below consensus. It now expects revenue in the range of $14.3M - $15M, below analysts' estimates of $16M. Post your comment!
-
AMAG Pharmaceuticals ( AMAG ) +4.7% premarket after announcing it has hired Jefferies as a strategic advisor to "explore all opportunities to enhance stockholder value," including a "potential sale of ...
AMAG Pharmaceuticals ( AMAG ) +4.7% premarket after announcing it has hired Jefferies as a strategic advisor to "explore all opportunities to enhance stockholder value," including a " potential sale of the company ." Post your comment!
-
AMAG Pharmaceuticals ([[ AMAG ]] +16.3%) shares rally after announcing a Q3 earnings beat, the resignation of its CEO, plans to cut a quarter of its employees, and a review of strategic options. “We’re ...
AMAG Pharmaceuticals ( AMAG +16.3% ) shares rally after announcing a Q3 earnings beat, the resignation of its CEO, plans to cut a quarter of its employees, and a review of strategic options. “We’re evaluating all strategic alternatives …
-
Amag to slash workforce, shares rise
(Reuters) - Amag Pharmaceuticals Inc's chief executive resigned and the biopharmaceuticals company said it will cut its workforce by a quarter to slash costs, sending its shares up 16 percent in...